READER FEEDBACK
Post a commentTrevena gets $7.65M grant for cell studies
Trevena, a privately held biotechnology company based in King of Prussia, today announced a $7.65 million grant from the National Institutes of Health to identify and characterize substances that affect cell behavior, which could lead to production of drugs with fewer side effects. - Miriam Hill
